Performance analysis of Armata Pharmaceuticals (ARMP)
Annual Return
Over the past 3 years, ARMP has had an average annual return of +69.80%, outperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, ARMP has had an average annual return of +13.88%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, ARMP has had an average annual return of -30.40%, underperforming the benchmark SPY, which returned +15.45% annual.
Since Mar 9, 2011, ARMP has had an average annual return of -29.95%, underperforming the benchmark SPY, which returned +14.10% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +22.22% | +227.27% | -42.11% | +171.43% | -77.42% | +82.35% | -10.53% | +11.76% | -79.01% | -76.99% | -88.94% | -61.17% |
| 2014 | 2013 | 2012 | 2011 | ||||||||
| -59.00% | +185.71% | +63.55% | -57.20% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.56% | +60.53% | -3.28% | -3.39% | -17.54% | -6.38% | +22.22% | ||||||
| 2025 | +0% | +0% | -27.27% | +12.50% | +22.22% | +0% | +27.27% | -0% | +21.43% | +64.71% | +50% | -14.29% | +227.27% |
| 2024 | +15.79% | +4.55% | +4.35% | -37.50% | +6.67% | +0% | +0% | -12.50% | -0% | -7.14% | +0% | -15.38% | -42.11% |
| 2023 | +142.86% | -11.76% | -33.33% | -10.00% | -11.11% | -12.50% | +100% | +42.86% | -15.00% | -23.53% | -0% | +46.15% | +171.43% |
| 2022 | -9.68% | +3.57% | -3.45% | -7.14% | -11.54% | -4.35% | +9.09% | -4.17% | +4.35% | -29.17% | -35.29% | -36.36% | -77.42% |
| 2021 | +64.71% | +14.29% | -15.63% | -14.81% | -0% | -0% | -4.35% | -4.55% | -0% | -14.29% | +55.56% | +10.71% | +82.35% |
| 2020 | +21.05% | -4.35% | -18.18% | +11.11% | +5% | +4.76% | -4.55% | -9.52% | -5.26% | +0% | +0% | -5.56% | -10.53% |
| 2019 | +23.53% | -4.76% | +20% | +12.50% | -33.33% | +27.78% | -13.04% | +25% | -16.00% | +14.29% | +4.17% | -24.00% | +11.76% |
| 2018 | +11.11% | +25.56% | -23.01% | -1.15% | +9.30% | -4.26% | -7.78% | -4.82% | +2.53% | -71.60% | -4.35% | -22.73% | -79.01% |
| 2017 | +2.84% | +8.29% | -12.24% | -38.37% | -72.17% | +5.08% | +17.74% | -6.85% | +7.35% | +17.81% | -3.49% | -2.41% | -76.99% |
Drawdown analysis of Armata Pharmaceuticals (ARMP)
The maximum drawdown for the ARMP was -99.98%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The current ARMP drawdown is -99.85%.
Since Mar 9, 2011 ARMP has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | Jul 24, 2013 | 2375 | Dec 28, 2022 | Ongoing | Ongoing | Ongoing |
| -78.97% | Mar 17, 2011 | 166 | Nov 10, 2011 | 417 | Jul 12, 2013 | 583 |
| -5.26% | Mar 11, 2011 | 3 | Mar 16, 2011 | 1 | Mar 17, 2011 | 4 |
| -2.50% | Jul 15, 2013 | 1 | Jul 16, 2013 | 1 | Jul 17, 2013 | 2 |
| -2.22% | Jul 18, 2013 | 1 | Jul 19, 2013 | 1 | Jul 22, 2013 | 2 |